GE Innovates, Arena Anxiety and 3 Active Stocks in the Spotlight
Gannett Co. (NYSE:GCI) has reaffirmed that it expects an annual revenue growth and greater earnings growth of 2%-4% by 2015. The company also reconfirm its plan to return over $1.3B to shareholders via its previously announced $0.80 per share dividend by 2015, and it intends to expand its $300M share repurchase commitment within the next two years.
General Electric Company (NYSE:GE) has created new service tool intended to better preventive maintenance, calls for tune-up and repair for the company’s appliances. NewFi, the New Field Inspector system, launched earlier this year provides GE Appliances with service technician repair technology to give more accurate assessments and diagnose possible performance problems, according to GE’s news release this week.
Bank of America Corp (NYSE:BAC): According to new SEC research, since the 1970s, money market mutual funds were rescued from financial problems by parent firms more than 300 times, nearly 100 more than previously thought. This seems to support SEC Chairman Mary Schapiro’s view that stronger regulation is needed in the $2.6T industry, the WSJ reports.
Investing Insights: 15 Banks That Are FIGHTING Back>>
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): Only FIVE days remain until Arena Pharmaceuticals’ FDA PDUFA date for its potentially huge obesity drug, Lorcaserin, possibly causing investors to feel more confident that a delay lasting 3-6 months. It should be noted that the company’s rival, Vivus, Inc.(NASDAQ:VVUS), announced a three month PDUFA delay for its drug Qnexa only eight days before its scheduled PDUFA date.
Micron Technology, Inc. (NASDAQ:MU), a flash memory developer, retreats following its report Wednesday night about higher than expected sales and lower than expected profits during Q3, but many analysts stay positive about Micron’s outlook. The company claims that its revenue growth was mainly generated by increased DRAM flash memory sales volumes.